Clinical Advisory: Medication Error Potential Found in EHRs, Erroneous Ordering of Airsupra™
A circumstance with the potential to produce medication errors has been identified within EHR/EMAR software in which the inhaler Airsupra™ (albuterol/budesonide) is being incorrectly ordered in place of albuterol sulfate products.
Deprescribing is a valuable tool for combatting polypharmacy and improving outcomes for residents, but it needs to be undertaken with care. This article discusses steps to effective deprescribing, including how to start and continue the conversation with residents and their families.
PharMerica has partnered with SinguLab, a nationwide provider of precision medicine solutions, to offer pharmacogenomic risk assessments and testing to help facilities and providers identify, monitor, and manage potential issues associated with resident medications.
While the MDS 3.0 1.18.11 went into effect on October 1, there have been changes since. Use this guide from Leah Klusch, RN, BSN, FACHCA, Executive Director of The Alliance Training Center, to understand the latest changes and the steps to stay in compliance.
A Look Back, the Path Forward: Outcomes and Impacts of the October 2022 Appendix PP Changes
Webinar 1 of 3:
Top F-Tags in 2023
This session takes a deep dive into the top 10 deficiencies and the events that triggered them. It will also explore the patterns and trends of non-compliance as well as scope and severity.
Learn how to use the quality improvement process to recover from deficiencies. This session includes action steps and resources to help your facility sustain compliance.
Walk through the survey aftermath with long-term and post-acute care leaders. Learn what solutions they implemented and how they ensured those solutions were sustainable.
